Icahn School of Medicine at Mount Sinai
New York, 10019, United States
NCT Number: NCT06620744
This prospective device study will examine the feasibility of MCG data collection in a hospital setting using the SandboxAQ MCG device as a potential method to more accurately and quickly quantify cardiac disease of patients with elevated Troponin.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
New York, 10019, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Unshielded device measuring cardiac magnetic fields.
Time frame: Per-scan, on average 5 minutes, day of enrollment
MCG Data Quality
Time frame: 30-days
Device-related adverse events
SB Technology, Inc.
Industry
Acronym: DUET
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04485754
ACS - Acute Coronary Syndrome, Acute Coronary Syndrome
Tyumen, Russia
View Trial DetailsNCT06095557
ACS - Acute Coronary Syndrome, Acute Coronary Syndrome
New York, United States
View Trial DetailsNCT05378321
ACS - Acute Coronary Syndrome, Acute Coronary Syndrome
Genk, Limburg, Belgium
View Trial DetailsNCT04219761
ACS - Acute Coronary Syndrome, Acute Coronary Syndrome
Tunis, Tunisia
View Trial Details